On June 22, 2022, Codex DNA Inc. (NASDAQ: DNAY) opened at $2.71, lower -3.74% from the last session. During the day, the shares moved up to $2.90 and dropped to $2.05 before settling in for the closing price of $2.14. Price fluctuations for DNAY have ranged from $2.11 to $25.70 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Company’s average yearly earnings per share was noted -247.00% at the time writing. With a float of $18.52 million, this company’s outstanding shares have now reached $29.33 million.
The firm has a total of 264 workers. Let’s measure their productivity. In terms of profitability, gross margin is +24.68, operating margin of -320.33, and the pretax margin is -352.66.
Codex DNA Inc. (DNAY) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Codex DNA Inc. is 0.40%, while institutional ownership is 59.30%.
Codex DNA Inc. (DNAY) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.45 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.43) by -$0.02. This company achieved a net margin of -352.78 while generating a return on equity of -119.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -247.00% per share during the next fiscal year.
Codex DNA Inc. (NASDAQ: DNAY) Trading Performance Indicators
Check out the current performance indicators for Codex DNA Inc. (DNAY). In the past quarter, the stock posted a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.52, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Codex DNA Inc. (DNAY)
Analysing the last 5-days average volume posted by the [Codex DNA Inc., DNAY], we can find that recorded value of 2.59 million was better than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 3.52%. Additionally, its Average True Range was 0.41.
During the past 100 days, Codex DNA Inc.’s (DNAY) raw stochastic average was set at 0.11%, which indicates a significant decrease from 0.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.43% in the past 14 days, which was lower than the 129.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.83, while its 200-day Moving Average is $7.57. Now, the first resistance to watch is $2.62. This is followed by the second major resistance level at $3.19. The third major resistance level sits at $3.47. If the price goes on to break the first support level at $1.77, it is likely to go to the next support level at $1.49. Should the price break the second support level, the third support level stands at $0.92.
Codex DNA Inc. (NASDAQ: DNAY) Key Stats
There are currently 29,398K shares outstanding in the company with a market cap of 61.80 million. Presently, the company’s annual sales total 11,040 K according to its annual income of -38,960 K. Last quarter, the company’s sales amounted to 5,640 K and its income totaled -13,190 K.